{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives", "item": "https://www.patentleaderboard.com/patent/8080580"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

US Patent 8080580 · Granted Dec 20, 2011

Estimated economic value: $148,634,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compositions for treatment of human immunodeficiency virus2023
Tissue-specific genome engineering using CRISPR-Cas92020
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2020
Therapeutic compositions for treatment of human immunodeficiency virus2020
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2019
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2018
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2017
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives2016
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives2016
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents2016
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives2016
Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives2014